MAPK3 and cancer: Additionally, we elucidated the associated mechanisms, which revealed that the G3842A mutation impairs mitochondrial function and increases ROS generation, which activates the ERK1/2 signaling pathway to facilitate cancer cell proliferation, invasion, and migration.